These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6321971)

  • 21. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
    Neve KA; Kozlowski MR; Marshall JF
    Brain Res; 1982 Jul; 244(1):33-44. PubMed ID: 6288182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.
    Strecker RE; Sharp T; Brundin P; Zetterström T; Ungerstedt U; Björklund A
    Neuroscience; 1987 Jul; 22(1):169-78. PubMed ID: 2819773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the cyclic nucleotides involvement in rat striatal function.
    Carenzi A; Govoni S; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1976 Oct; 8(5):519-24. PubMed ID: 194261
    [No Abstract]   [Full Text] [Related]  

  • 25. Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation.
    Herrera-Marschitz M; Utsumi H; Ungerstedt U
    J Neurol Neurosurg Psychiatry; 1990 Jan; 53(1):39-43. PubMed ID: 2303830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway.
    Mandel RJ; Yurek DM; Randall PK
    Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
    Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

  • 34. Transplantation of dopamine-containing tissues to the central nervous system.
    Hoffer B; Freed W; Olson L; Wyatt RJ
    Clin Neurosurg; 1983; 31():404-16. PubMed ID: 6687303
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function of nigral dopamine receptors?
    Glick SD; Crane LA
    Brain Res; 1978 Nov; 156(2):380-1. PubMed ID: 568507
    [No Abstract]   [Full Text] [Related]  

  • 37. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of diphenylhydantoin on central catecholamine containing neuronal systems.
    Elliott PN; Jenner P; Chadwick D; Reynolds E; Marsden CD
    J Pharm Pharmacol; 1977 Jan; 29(1):41-3. PubMed ID: 13181
    [No Abstract]   [Full Text] [Related]  

  • 39. Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
    Rogers DC; Dunnett SB
    Behav Brain Res; 1989 Aug; 34(1-2):131-46. PubMed ID: 2504223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system.
    Garcia-Munoz M; Patino P; Wright AJ; Arbuthnott GW
    Neuroscience; 1983 Jan; 8(1):87-95. PubMed ID: 6300729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.